Last updated on September 2018

VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease


Brief description of study

Vedolizumab has been approved for the treatment of both ulcerative colitis and Crohn's disease. The aim of this study is to capture the early real life UK experience of vedolizumab including the outcomes of treatment, describing the patient population treated, drug persistence, IBD control PROM, durable remission, tolerance and safety.

Clinical Study Identifier: NCT03257345

Find a site near you

Start Over

Barts Health NHS Trust

London, United Kingdom
  Connect »

West Suffolk NHS Foundation Trust

Bury Saint Edmunds, United Kingdom
  Connect »

The Royal Wolverhampton NHS Trust

Wolverhampton, United Kingdom
  Connect »